Shiv Krishna Biogen was founded in 2018 by a group of young and experienced techno-commercial professionals in Morbi, Gujarat, India. As part of the Shiv Krishna Biogen aspires to emerge as a leading expert in the manufacturing of intermediates and active pharmaceutical ingredients (APIs), providing comprehensive end-to-end support to global healthcare companies.

With a team of experienced scientists and engineers, and by adhering to the industry’s best manufacturing practices, Shiv Krishna Biogen is well-positioned to efficiently supply high-quality bulk drugs and intermediates worldwide. The company offers end-to-end support to its clients, including process development, analytical development, scale-up, and regulatory compliance.